I have truly exciting news for you today!

While I usually save new stock recommendations for our monthly newsletters, from time to time, there comes a company whose potential is so great that I can’t waste another moment before I send it to you.

And given that my newsletters are restricted to eight pages, there’s always extra information that my editor is forced to cut.

That’s where today’s exciting news comes in.

My team and I have just put the finishing touches on two brand-new reports for you.

One is about a company that is set to soar as it tackles the COVID-19 crisis head on.

And the second is a list of stocks I see doomed to fail thanks to this very same pandemic.

I want to save the full details for the reports, but allow me to give you a quick look at each of these premium issues.

Report No. 1: The Race for a COVID-19 Solution

It’s no secret: When a company gets approval from the Food and Drug Administration (FDA) to help treat a deadly disease, its stock can skyrocket.

We will get through this COVID-19 pandemic. I see light beyond the battered horizon.

And I am confident a handful of stocks will lead the market out of the doldrums to record highs.

As you may have guessed, we’ll see the biggest winners in the biotech sector.

And I see one Massachusetts biotech stock that’s a screaming “BUY” right now.

It’s bringing a much-needed diagnostic test to a market starving for resources — and in record time!

In our first new special report, I spill the details on how you can position yourself to profit, before its shares take off.

The report is called The Biotech Supporting the Race for a COVID-19 Solution.

Inside, you’ll discover…

• The name and ticker symbol, so you can profit on the company leading the test kit market AND working to support vaccine developers.
• The best strategy for getting in the stock for the chance to capture the biggest profits. And…
• The latest updates on its research and development as it fights to eradicate COVID-19 once and for all.

Listen, this company has $25 billion in annual revenue, but the market’s recent drop has caused its stock to suffer.

But it’s severely undervalued, creating a golden opportunity for you to get in right now.

To learn more about this opportunity, click here.

Report No. 2: The Blacklist

Now, we can’t ignore the fact that the markets are more volatile than any time in economic history.

We’ve seen the Dow Jones Industrial Average have its biggest drop ever, losing nearly 3,000 points in a single day.

Then, just eight days later, it had its biggest single-day gain in history … surging 2,100 points.

These extremes are becoming the new norm.

Which is why now is the worst time to be complacent with investments.

You need to be proactive.

With over 90% of the nation forced to stay at home, many stocks are taking big hits.

Companies such as Cheesecake Factory, Disney and Apple are a few that come to mind.

In my research, I found 10 stocks you must avoid at all costs during AND after the coronavirus.

These stocks are taking huge hits to their bottom lines, and I don’t see things turning around anytime soon.

Fact is, some might take years to recover…

Some may never recover.

In our new report, I list each of these stocks that you should sell right away.

It’s called The Blacklist: 10 Stocks to Dump Right Now.

This could save you big losses in the days ahead.

To discover if you have any of these financial pitfalls in your portfolio, make sure to read your latest report right away by clicking here.

As always, if you have questions about your new reports, email my team and me at totalwealthinsider@banyanhill.com.

I’ll back on Sunday with your weekly update.

Best of Good Buys,

Jeff Yastine
Editor, Total Wealth Insider